IMPACT OF MEDICATION ADHERENCE TO DISEASE-MODIFYING DRUGS ON SEVERE RELAPSE, AND DIRECT AND INDIRECT COSTS AMONG EMPLOYEES WITH MULTIPLE SCLEROSIS

¹Analysis Group, Inc., New York, NY, USA, ²EMD Serono, Inc., Rockland, MA, USA, ³Analysis Group, Inc., Boston, MA, USA, ⁴Pfizer Inc, New London, CT, USA